This is a proof (draft) Hansard, not the final version.

The Parliament has not yet published the final text for this day, so the wording, who said what and the results of divisions may change.

Senate debates Bills

Therapeutic Goods Amendment (Medicines Shortages and Other Measures) Bill 2026, Therapeutic Goods (Charges) Amendment Bill 2026; Second Reading


Anne Ruston

Anne Ruston SA, Liberal Party, Shadow Minister for Health and Aged Care

7:22 pm

I rise to speak on the Therapeutic Goods Amendment (Medicines Shortages and Other Measures) Bill 2026 and the related Therapeutic Goods (Charges) Amendment Bill 2026. Let me say at the outset the coalition will not be opposing these bills, but I want to be very clear about what these bills do and what they don't do. The Therapeutic Goods Amendment (Medicines Shortages and Other Measures) Bill 2026 is about knowing sooner that a medicine is about to run out. It is not a bill about making sure that that medicine doesn't run out.

Under this bill, a company that decides to stop supplying a reportable medicine in Australia must tell the regulator at least 12 months ahead or as soon as it practically can. If that plan changes, it must say so. The secretary will be able to ask the supplier of any approved medicine—not just a reportable one—whether it's available, running short or on its way out altogether. The Medicines Watch List, the list of medicines whose loss would hurt patients most, will be kept current as the documents it relies on change.

The bill also lets near-identical biological medicines from the same company share one entry on the register, rather than a new listing for every pack size. The charges bill sets the fees for those groups. There will be less duplication and less red tape, and that's sensible. It puts beyond doubt the power of authorised officers to enter and inspect clinical trial sites so the people who volunteer for those trials can trust that they're being given in a safe environment. None of that is controversial.

Since this bill passed the other place in August, the Community Affairs Legislation Committee has examined it and reported. The nurses and midwives called it a positive first step and said more work was needed. The physicians told the committee that the bill on its own is unlikely to deliver a comprehensive solution. They support the bill and so do we, but none of them believes it solves the problem, because there is a problem.

Australia import about 90 per cent of the medicines that we rely on, and we account for barely two per cent of the global market. When a factory overseas stumbles or a shipping route closes, we are a long way down the queue. We saw that again this year. When conflict broke out in the Middle East in March, medicines bound for Australia had to be rerouted. Throughout 2025, more than 400 medicines were listed as in shortage on any given day. That has not improved. Just weeks ago, the number was around 420. Forty of them were considered critical.

And they keep coming back. An analysis of the TGA's own data published just last week found that more than half of those critical shortages had happened before and thirteen of those medicines had been critically short more than once. Take Bicillin, a long-acting penicillin used to treat syphilis and to protect people living with rheumatic heart disease. It has been in short supply since April last year, our emergency supplies ran out in September and relief is not expected until next March. For Aboriginal and Torres Strait Islander communities, where rheumatic heart disease is still far too common, that is not an inconvenience; it is plainly dangerous.

Think about what that means at the pharmacy counter. It means an older Australian who has taken the same tablet for years being told it simply isn't available, and far too often the GP is the last to find out. When nearly 1,500 GPs were polled earlier last year, almost three in four said they usually first heard about a shortage from their patients. The patients told the doctor. That is a backwards way of going about it. So, yes, earlier warning certainly helps, but a warning is not a solution. You cannot fill a prescription with a notice.

We know prevention can work because we've seen it. It was the coalition that made medicine shortages reporting mandatory from January 2019 and it was the coalition that legislated the minimum stockholding requirements so companies must hold months of stock of key PBS medicines here in Australia. Earlier this year, the department's own review found those requirements had reduced both the number and the severity of shortages.

That is what it looks like when you stop a shortage before it starts. Contrast that with the government's handling of IV fluids—the saline drips that every operating theatre and emergency department depends on. By the government's own admission, it knew a shortage was coming from the middle of May 2023. By the middle of 2024, hospitals were told that they had to ration. At the time, I asked a simple question: what does a future made in Australia actually mean if the government can't even guarantee a supply of saline solution? The answer came in March 2025—a $20 million investment matched by industry to expand local production—and we welcomed it. We welcomed the fact that the acute shortage was to be resolved. The minister told Australians we would no longer be hostage to overseas supply, but the full extra capacity is not due until 2027. That's around four years from the first warning that a fix was needed.

That brings me to our two amendments. The coalition will move two amendments. The first is the second reading amendment circulated in my name. When it was moved in the other place, the government voted it down. We will move it again here because the problem has not gone away. It asks the Senate to recognise how dependent we are on imports, how stubborn the number of shortages has been and that substitution approvals have more than doubled since 2018. It notes that this bill does not deal with the underlying cause. It calls on the government to do what it has so far avoided doing—to develop a comprehensive medicine shortage policy to build our sovereign capability so more essential medicines are made here at home in Australia and to set targets to bring the number of shortages down.

The second amendment, which I'll move in the committee stage, puts that work into law. It requires the minister to commission regular independent reviews of Australia's medicines security. The first must begin within six months of this law taking effect and be finished within a year—and, after that, there must be a fresh review at least every five years. When the same medicines run short again and again, that is not bad luck; it is a pattern. A pattern can be found and a pattern can be fixed. Each review must look at the questions that these bills leave unanswered—how much we rely on medicines and ingredients made overseas, which critical medicines have no safe substitute, whether we are holding enough stock and whether we could make more of it here, and what shortages mean for hospitals, for aged care, for general practice, for Aboriginal community controlled health services and for patients in rural, regional and remote Australia. It must hear from people who live with this every day—doctors, nurses, pharmacists, patients, wholesalers, manufacturers and state and territory governments. The report must be tabled in this parliament, and the government must table its response to every recommendation within six months. It will not stop every shortage—nothing can—but it means the hard questions get asked and answered out in the open before the next crisis rather than after it. If no-one measures it, no-one is accountable for it.

The coalition will not stand in the way of these bills. They will help Australians see the next shortage coming. But our job in this place is to make sure it never arrives at all. An early warning is welcome, but a warning is not a solution. I commend our amendments to the Senate and I urge the government and the crossbench to support them, because patients and the people who care for them deserve nothing less.

Comments

No comments